The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

Simple item page
dc.contributor.authorBousquet J.
dc.contributor.authorToumi M.
dc.contributor.authorSousa-Pinto B.
dc.contributor.authorAnto J.M.
dc.contributor.authorBedbrook A.
dc.contributor.authorCzarlewski W.
dc.contributor.authorValiulis A.
dc.contributor.authorAnsotegui I.J.
dc.contributor.authorBosnic-Anticevich S.
dc.contributor.authorBrussino L.
dc.contributor.authorCanonica G.W.
dc.contributor.authorCecchi L.
dc.contributor.authorCherrez-Ojeda I.
dc.contributor.authorChivato T.
dc.contributor.authorCosta E.M.
dc.contributor.authorCruz A.A.
dc.contributor.authorDel Giacco S.
dc.contributor.authorFonseca J.A.
dc.contributor.authorGemicioglu B.
dc.contributor.authorHaahtela T.
dc.contributor.authorIvancevich J.C.
dc.contributor.authorJutel M.
dc.contributor.authorKaidashev I.
dc.contributor.authorKlimek L.
dc.contributor.authorKvedariene V.
dc.contributor.authorKuna P.
dc.contributor.authorLarenas-Linnemann D.E.
dc.contributor.authorLipworth B.
dc.contributor.authorMorais-Almeida M.
dc.contributor.authorMullol J.
dc.contributor.authorPapadopoulos N.G.
dc.contributor.authorPatella V.
dc.contributor.authorPham-Thi N.
dc.contributor.authorRegateiro F.S.
dc.contributor.authorRouadi P.W.
dc.contributor.authorSamolinski B.
dc.contributor.authorSheikh A.
dc.contributor.authorTaborda-Barata L.
dc.contributor.authorVentura M.T.
dc.contributor.authorYorgancioglu A.
dc.contributor.authorZidarn M.
dc.contributor.authorZuberbier T.
dc.date.accessioned2024-07-22T08:04:00Z
dc.date.available2024-07-22T08:04:00Z
dc.date.issued2022
dc.description.abstractDrug repurposing is a major field of value-added medicine. It involves investigating and evaluating existing drugs for new therapeutic purposes that address unmet healthcare needs. Several unmet needs in allergic rhinitis could be improved by drug repurposing. This could be game-changing for disease management. Current medications for allergic rhinitis are centered on continuous long-term treatment, and medication registration is based on randomized controlled trials carried out for a minimum of 14 days with adherence of 70% or greater. A new way of treating allergic rhinitis is to propose as-needed treatment depending on symptoms, rather than classical continuous treatment. This rostrum will discuss existing clinical trials on as-needed treatment for allergic rhinitis and real-world data obtained by the mobile health app MASK-air, which focuses on digitally-enabled, patient-centered care pathways. © 2022 American Academy of Allergy, Asthma & Immunology
dc.identifier.DOI-ID10.1016/j.jaip.2022.07.020
dc.identifier.issn22132198
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12529
dc.language.isoEnglish
dc.publisherAmerican Academy of Allergy, Asthma and Immunology
dc.rightsAll Open Access; Bronze Open Access
dc.subjectAsthma
dc.subjectDisease Management
dc.subjectHumans
dc.subjectMobile Applications
dc.subjectRhinitis, Allergic
dc.subjectTelemedicine
dc.subjectantihistaminic agent
dc.subjectcorticosteroid
dc.subjectdexamethasone
dc.subjectfluticasone furoate
dc.subjectfluticasone propionate
dc.subjecthydroxychloroquine
dc.subjectivermectin
dc.subjectnon prescription drug
dc.subjectsildenafil
dc.subjectallergic rhinitis
dc.subjectArticle
dc.subjectasthma
dc.subjectcontrolled study
dc.subjectdesensitization
dc.subjectdisease exacerbation
dc.subjectdisease severity
dc.subjectdrug repositioning
dc.subjecthealth care access
dc.subjecthealth care delivery
dc.subjecthealth promotion
dc.subjecthuman
dc.subjectlong term care
dc.subjectmedicine
dc.subjectoutcome assessment
dc.subjectpatient care
dc.subjectpeak inspiratory flow
dc.subjectprevalence
dc.subjectquality of life
dc.subjectquestionnaire
dc.subjectrandomized controlled trial
dc.subjectrandomized controlled trial (topic)
dc.subjectsocial interaction
dc.subjecttotal quality management
dc.subjectvisual analog scale
dc.subjectallergic rhinitis
dc.subjectasthma
dc.subjectdisease management
dc.subjectmobile application
dc.subjecttelemedicine
dc.titleThe Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
dc.typeArticle

Files

Collections

Scopus Koleksiyonu